MediciNova, Inc. (MNOV)
1.42
-0.03
(-2.07%)
USD |
NASDAQ |
Oct 16, 16:00
1.43
+0.01
(+0.70%)
After-Hours: 20:00
MediciNova Net Income (TTM) : -10.75M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.75M |
| March 31, 2026 | -11.72M |
| December 31, 2025 | -12.00M |
| September 30, 2025 | -12.01M |
| June 30, 2025 | -11.81M |
| March 31, 2025 | -11.16M |
| December 31, 2024 | -11.05M |
| September 30, 2024 | -10.29M |
| June 30, 2024 | -8.165M |
| March 31, 2024 | -8.408M |
| December 31, 2023 | -8.572M |
| September 30, 2023 | -9.514M |
| June 30, 2023 | -12.44M |
| March 31, 2023 | -13.60M |
| December 31, 2022 | -14.07M |
| September 30, 2022 | -13.15M |
| June 30, 2022 | -13.08M |
| March 31, 2022 | -13.33M |
| December 31, 2021 | -10.13M |
| September 30, 2021 | -11.04M |
| June 30, 2021 | -11.16M |
| March 31, 2021 | -11.33M |
| December 31, 2020 | -13.85M |
| September 30, 2020 | -12.85M |
| June 30, 2020 | -11.53M |
| Date | Value |
|---|---|
| March 31, 2020 | -10.96M |
| December 31, 2019 | -12.94M |
| September 30, 2019 | -11.17M |
| June 30, 2019 | -15.57M |
| March 31, 2019 | -14.83M |
| December 31, 2018 | -14.68M |
| September 30, 2018 | -16.07M |
| June 30, 2018 | -13.05M |
| March 31, 2018 | -12.69M |
| December 31, 2017 | -11.16M |
| September 30, 2017 | -11.01M |
| June 30, 2017 | -10.09M |
| March 31, 2017 | -10.50M |
| December 31, 2016 | -10.87M |
| September 30, 2016 | -12.15M |
| June 30, 2016 | -10.92M |
| March 31, 2016 | -10.01M |
| December 31, 2015 | -8.845M |
| September 30, 2015 | -8.491M |
| June 30, 2015 | -9.223M |
| March 31, 2015 | -9.058M |
| December 31, 2014 | -9.195M |
| September 30, 2014 | -3.401M |
| June 30, 2014 | -3.298M |
| March 31, 2014 | -3.962M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 129.87M |
| Viking Therapeutics, Inc. | -534.80M |
| IDEAYA Biosciences, Inc. | -175.02M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |